Interesting post here that people might want to comment on..
-
-
I really believe that, genetic test will popular in ten years, as the time when people understand that the genetic test just test the risk of the gene variation instead of determination of the disease. -
I am spending the final chapter of my thesis - which is generally on CNVs in psychiatric disease - on the topic of DTC testing and medical relevance of genetic research results. I have interviewed some experts from the fields of psychiatry, clinical genetics, and epidemiology. Interesting to see how different they all look at the future usibility of genetic associations and other genetic reserach results. Has anyone ever taken such a DTC test? Would be interesting to see results.Comment
-
Can you get to Boston, Mass.?
If you have access Boston, Mass. by any means, you can sign up and volunteer to get your genome sequenced and see for yourself.
Comment
-
More interested in interpretation
Thanks for the offer, Joann. I have actually thought of signing up, and am still contemplating. For the purpose of my societal chapter, I would actually be more interested in the interpretation that test provideers give to the variation they find. I know what happens in their labs (I am doing the same thing in our lab: sequencing, microarrays), but I would love to see what sort of medical reports they send to people who take the tests.Comment
-
Scientific oversight encouraged
At this point, what you or any other interested scientist can do at any time is go to the NIH sponsored web site Gene Tests at
look at the Clinical Test Listings and choose a gene (and a lab) of relevance that you would be interested in being tested for. That way, the diagnostic reports generated by the lab providing your test would go to you and would cover your personal genetics for that gene.
In fact, this might make a very interesting, informative organized group project/discussion.Comment
-
non-clinical testing labs
Hey Joann,
Thanks for this link. As far as can see, it displays a different type of genetic testing labs than the ones the original article was referring to, namely the certified, clinical testing labs within hospitals and public institutes. DecodeMe is not such a lab, nor is 23andMe, Navigenics and a whole other bunch of companies. That is the category that I would be interested in. Discussing their relevance and impact, especially since we know their tests are clinically not (yet) relevant, would be interesting.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment